Dias M, Mornet R, Laloue M
Laboratoire de Chimie Organique Fondamentale et Appliquée, Faculté des Sciences, Angers, France.
Bioorg Med Chem. 1995 Apr;3(4):361-6. doi: 10.1016/0968-0896(95)00035-f.
1-(2-Azido-6-chloropyrid-4-yl)-3-phenylurea was synthesized using known methods. Azido-tetrazole equilibrium for this compound was studied in various solvents, and the azide tautomer was found to be largely predominant. However, in water solution, it is suspected to exist in the tetrazole form in a significant amount. Like other 2,6-disubstituted pyridylurea analogs, it exhibits high cytokinin activity, and it is easily photolysable. Thus it appears to be a good candidate as a photoaffinity labeling reagent for cytokinin-binding proteins, receptors in particular. In the absence of the 6-chloro substituent, the tetrazole form was the only existing tautomer. The corresponding compound does not exhibit cytokinin activity and is not photolysable.
1-(2-叠氮基-6-氯吡啶-4-基)-3-苯基脲采用已知方法合成。研究了该化合物在各种溶剂中的叠氮基-四唑平衡,发现叠氮互变异构体占主导地位。然而,在水溶液中,怀疑它大量以四唑形式存在。与其他2,6-二取代吡啶脲类似物一样,它表现出高细胞分裂素活性,且易于光解。因此,它似乎是作为细胞分裂素结合蛋白,特别是受体的光亲和标记试剂的良好候选物。在没有6-氯取代基的情况下,四唑形式是唯一存在的互变异构体。相应的化合物不表现出细胞分裂素活性,也不能光解。